301206 三元生物
已收盘 09-09 15:00:00
资讯
新帖
简况
股市必读：三元生物(301206)股东户数1.49万户，较上期减少3.22%
证券之星 · 00:37
股市必读：三元生物(301206)股东户数1.49万户，较上期减少3.22%
国际原糖创新高！全球糖市供应紧张，代糖赛道迎来替代红利
中金财经 · 09-08 18:10
国际原糖创新高！全球糖市供应紧张，代糖赛道迎来替代红利
三元生物：截至8月31日公司在册股东共14915户
证券之星 · 09-08 11:33
三元生物：截至8月31日公司在册股东共14915户
三元生物（301206）披露继续使用暂时闲置超募资金进行现金管理进展公告，9月1日股价上涨1.01%
证券之星 · 09-01
三元生物（301206）披露继续使用暂时闲置超募资金进行现金管理进展公告，9月1日股价上涨1.01%
三元生物（301206）2026年中报简析：增收不增利，公司应收账款体量较大
证券之星 · 08-29
三元生物（301206）2026年中报简析：增收不增利，公司应收账款体量较大
三元生物最新公告：拟3000万元增资山东晶体公司
证券之星 · 08-28
三元生物最新公告：拟3000万元增资山东晶体公司
三元生物(301206)8月20日股东户数1.54万户，较上期增加0.07%
证券之星 · 08-28
三元生物(301206)8月20日股东户数1.54万户，较上期增加0.07%
股市必读：三元生物新发布《2026年半年度报告摘要》
证券之星 · 08-28
股市必读：三元生物新发布《2026年半年度报告摘要》
图解三元生物中报：第二季度单季净利润同比下降25.37%
证券之星 · 08-28
图解三元生物中报：第二季度单季净利润同比下降25.37%
三元生物：截至8月20日公司在册股东共15411户
证券之星 · 08-25
三元生物：截至8月20日公司在册股东共15411户
三元生物（301206）披露对外投资提示性公告，8月20日股价上涨3.25%
证券之星 · 08-20
三元生物（301206）披露对外投资提示性公告，8月20日股价上涨3.25%
三元生物最新公告：拟参与中材人工晶体研究院山东公司增资项目
证券之星 · 08-19
三元生物最新公告：拟参与中材人工晶体研究院山东公司增资项目
三元生物：85000吨柔性产线覆盖塔格糖需求
证券之星 · 08-18
三元生物：85000吨柔性产线覆盖塔格糖需求
股市必读：三元生物（301206）8月14日董秘有最新回复
证券之星 · 08-17
股市必读：三元生物（301206）8月14日董秘有最新回复
三元生物：Reb M已具备规模化生产能力
证券之星 · 08-14
三元生物：Reb M已具备规模化生产能力
股市必读：三元生物(301206)股东户数1.54万户，较上期增加3.04%
证券之星 · 08-14
股市必读：三元生物(301206)股东户数1.54万户，较上期增加3.04%
三元生物：截至8月10日公司在册股东共15400户
证券之星 · 08-13
三元生物：截至8月10日公司在册股东共15400户
三元生物：阿洛酮糖业务整体保持稳健推进态势
证券之星 · 08-12
三元生物：阿洛酮糖业务整体保持稳健推进态势
三元生物（301206）披露对外投资进展暨完成工商变更登记公告，8月5日股价下跌0.17%
证券之星 · 08-05
三元生物（301206）披露对外投资进展暨完成工商变更登记公告，8月5日股价下跌0.17%
股市必读：三元生物(301206)股东户数1.49万户，较上期增加0.97%
证券之星 · 08-05
股市必读：三元生物(301206)股东户数1.49万户，较上期增加0.97%
加载更多
公司概况
公司名称：
山东三元生物科技股份有限公司
所属行业：
食品制造业
上市日期：
2022-02-10
主营业务：
山东三元生物科技股份有限公司的主营业务是糖醇类、功能糖类及糖苷类健康甜味配料的研发、生产与销售。公司的主要产品是糖醇类、功能糖类及糖苷类健康甜味配料。公司已拥有40项国家发明专利和3项实用新型专利。
发行价格：
109.30
{"stockData":{"symbol":"301206","market":"SZ","secType":"STK","nameCN":"三元生物","latestPrice":29,"timestamp":1788937386000,"preClose":27,"halted":0,"volume":21534898,"delay":0,"changeRate":0.0741,"floatShares":130000000,"shares":202000000,"eps":0.4168,"marketStatus":"已收盘","change":2,"latestTime":"09-09 15:00:00","open":26.31,"high":29.16,"low":26.08,"amount":603000000,"amplitude":0.1141,"askPrice":29,"askSize":1303,"bidPrice":28.99,"bidSize":614,"shortable":0,"etf":0,"ttmEps":0.4168,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789003800000},"marketStatusCode":5,"adr":0,"adjPreClose":27,"symbolType":"stock","openAndCloseTimeList":[[1788917400000,1788924600000],[1788930000000,1788937200000]],"highLimit":29.7,"lowLimit":24.3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":202325700,"isCdr":false,"pbRate":1.3,"roa":"--","peRate":69.577735,"roe":"1.19%","epsLYR":0.46,"committee":-0.188031,"marketValue":5867000000,"turnoverRate":0.1653,"status":0,"floatMarketCap":3778000000},"requestUrl":"/m/hq/s/301206","defaultTab":"news","newsList":[{"id":"2666374331","title":"股市必读：三元生物(301206)股东户数1.49万户，较上期减少3.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666374331?lang=zh_cn&edition=full","pubTime":"2026-09-09 00:37","pubTimestamp":1788885437,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，三元生物报收于27.0元，上涨14.26%，换手率11.95%，成交量15.58万手，成交额4.15亿元。股本股东变化股东户数变动截至2026年8月31日公司股东户数为1.49万户，较8月20日减少496.0户，减幅为3.22%。户均持股数量由上期的1.31万股增加至1.36万股，户均持股市值为32.37万元。谢谢董秘： 投资者您好，截至8月31日公司在册股东共14915户，谢谢关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900001793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665214023","title":"国际原糖创新高！全球糖市供应紧张，代糖赛道迎来替代红利","url":"https://stock-news.laohu8.com/highlight/detail?id=2665214023","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665214023?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:10","pubTimestamp":1788862201,"startTime":"0","endTime":"0","summary":"据广发期货研报，印度、巴西、泰国等主产区供应担忧升温，ICE原糖创16个月新高，糖价上涨强化代糖替代逻辑。供需格局逆转之下，全球食糖市场正式从过剩转向短缺。国际糖价上涨带动全球代糖替代需求提升，国内代糖企业有望充分承接海外订单增量，同时受益于国内下游需求复苏，内外销共振将推动企业营收、利润持续修复。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908209943.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908209943.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260908/32363655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0229","301206","BK0004","BK0012","BK0010","000523","002286","BK0105","BK0082","BK0227","BK0028","BK0164","BK0173","BK0039","000930","BK0188","600108","BK0110","BK0104","BK0070","605077","BK0226","BK0007","BK0199","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344513","title":"三元生物：截至8月31日公司在册股东共14915户","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665344513?lang=zh_cn&edition=full","pubTime":"2026-09-08 11:33","pubTimestamp":1788838395,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)09月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问8月31日股东人数是多少？谢谢三元生物回复：投资者您好，截至8月31日公司在册股东共14915户，谢谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800015103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664285704","title":"三元生物（301206）披露继续使用暂时闲置超募资金进行现金管理进展公告，9月1日股价上涨1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664285704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664285704?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:54","pubTimestamp":1788274454,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，三元生物报收于24.1元，较前一交易日上涨1.01%，最新总市值为48.76亿元。该股当日开盘23.86元，最高24.26元，最低23.74元，成交额达3703.75万元，换手率为1.18%。三元生物于2026年9月1日披露《关于继续使用暂时闲置超募资金进行现金管理的进展公告》。公告显示，公司于近日使用闲置超募资金50,800万元购买中国光大银行结构性存款产品，产品类型为保本浮动收益，起止日期为2026年9月1日至2026年9月30日，预期年化收益率为0.75%/1.75%/1.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663501624","title":"三元生物（301206）2026年中报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2663501624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663501624?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:51","pubTimestamp":1787957482,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期三元生物发布2026年中报。截至本报告期末，公司营业总收入4.29亿元，同比上升34.83%，归母净利润5039.76万元，同比下降12.32%。本报告期三元生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达83.93%。本次财报公布的各项数据指标表现一般。财报体检工具显示：建议关注公司现金流状况建议关注公司应收账款状况本文数据来源于三元生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900013183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662989130","title":"三元生物最新公告：拟3000万元增资山东晶体公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662989130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662989130?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:19","pubTimestamp":1787919574,"startTime":"0","endTime":"0","summary":"三元生物(301206.SZ)公告称，近日，公司收到北京产权交易所出具的《意向投资方资格确认通知书》，被正式确认为本次增资项目的合格投资方之一。公司拟使用自有资金向中材人工晶体研究院（山东）有限公司增资人民币3,000万元，完成后将持有标的公司4.8844%股权。本次交易不构成关联交易及重大资产重组。本次对外投资是在立足核心主业稳健发展的基础上，进一步深化对光学材料及器件领域的布局，为公司培育中长期的第二增长曲线。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800049633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069584","title":"三元生物(301206)8月20日股东户数1.54万户，较上期增加0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069584","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662069584?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:56","pubTimestamp":1787911014,"startTime":"0","endTime":"0","summary":"证券之星消息，近日三元生物披露，截至2026年8月20日公司股东户数为1.54万户，较8月10日增加11.0户，增幅为0.07%。在化学制品行业个股中，三元生物股东户数低于行业平均水平，截至8月20日，化学制品行业平均股东户数为3.09万户。从股价来看，2026年8月10日至2026年8月20日，三元生物区间涨幅为2.91%，在此期间股东户数增加11.0户，增幅为0.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031480","title":"股市必读：三元生物新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031480","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662031480?lang=zh_cn&edition=full","pubTime":"2026-08-28 07:28","pubTimestamp":1787873295,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，三元生物报收于23.8元，上涨0.0%，换手率0.94%，成交量1.22万手，成交额2902.79万元。公司公告汇总：董事会审议通过2026年半年度利润分配预案，拟每10股派发现金红利2.50元（含税），共计5000万元，尚需提交股东大会审议。公司公告汇总：2026年半年度报告摘要显示，营业收入同比增长34.83%，但归母净利润同比下降12.32%；经营活动现金流量净额同比大增3730.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800013810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087900","title":"图解三元生物中报：第二季度单季净利润同比下降25.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087900","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662087900?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:30","pubTimestamp":1787855430,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物2026年中报显示，上半年度公司主营收入4.29亿元，同比上升34.83%；归母净利润5039.76万元，同比下降12.32%；扣非净利润4294.15万元，同比下降11.93%；其中2026年第二季度，公司单季度主营收入2.04亿元，同比上升21.56%；单季度归母净利润2430.61万元，同比下降25.37%；单季度扣非净利润2007.87万元，同比下降27.91%；负债率6.46%，投资收益2314.34万元，财务费用231.56万元，毛利率17.59%。财报数据概要请见下图:本文数据来源于三元生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800005986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662202418","title":"三元生物：截至8月20日公司在册股东共15411户","url":"https://stock-news.laohu8.com/highlight/detail?id=2662202418","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662202418?lang=zh_cn&edition=full","pubTime":"2026-08-25 08:48","pubTimestamp":1787618893,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)08月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问截止8月20日股东人数是多少？谢谢三元生物回复：投资者您好，截至8月20日公司在册股东共15411户，谢谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500012966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660928827","title":"三元生物（301206）披露对外投资提示性公告，8月20日股价上涨3.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660928827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660928827?lang=zh_cn&edition=full","pubTime":"2026-08-20 17:53","pubTimestamp":1787219639,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，三元生物报收于24.78元，较前一交易日上涨3.25%，最新总市值为50.14亿元。该股当日开盘24.3元，最高24.8元，最低24.17元，成交额达5966.34万元，换手率为1.86%。近日，三元生物披露《关于对外投资的提示性公告》。公告显示，公司拟参与中材人工晶体研究院（山东）有限公司增资项目，投资金额不超过人民币3,000万元。投资完成后公司持股比例较低，不纳入合并报表范围，短期内对公司财务状况无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000032406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660442851","title":"三元生物最新公告：拟参与中材人工晶体研究院山东公司增资项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2660442851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660442851?lang=zh_cn&edition=full","pubTime":"2026-08-19 20:00","pubTimestamp":1787140843,"startTime":"0","endTime":"0","summary":"三元生物(301206.SZ)公告称，公司拟作为意向投资方参与中材人工晶体研究院(山东)有限公司增资项目，拟投资金额不超过3000万元。标的公司聚焦红外光学材料及制品产业，本次投资旨在深化光学材料领域布局，培育第二增长曲线。最终投资金额及持股比例将根据北京产权交易所交易规则确定，本次投资不构成关联交易及重大资产重组。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900038090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453555","title":"三元生物：85000吨柔性产线覆盖塔格糖需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453555","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660453555?lang=zh_cn&edition=full","pubTime":"2026-08-18 08:42","pubTimestamp":1787013732,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物08月17日在投资者关系平台上答复投资者关心的问题。公司正在建设的“赤藓糖醇生产线改造提升85000吨生物合成产品项目”为柔性化产线，具备多品种灵活切换能力，其产能规模足以覆盖塔格糖从市场推广到未来规模化放量的订单需求，现阶段无需新增额外产能投资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800007496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660410866","title":"股市必读：三元生物（301206）8月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660410866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660410866?lang=zh_cn&edition=full","pubTime":"2026-08-17 03:45","pubTimestamp":1786909514,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，三元生物报收于23.85元，下跌0.54%，换手率0.75%，成交量9799.0手，成交额2335.08万元。甜菊糖苷和罗汉果甜苷作为天然高倍甜味剂的代表，是公司复配赤藓糖醇、阿洛酮糖、塔格糖等天然低倍甜味剂的重要原料。当日关注点交易信息汇总：8月14日游资资金净流入145.77万元，占总成交额6.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700001388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659116437","title":"三元生物：Reb M已具备规模化生产能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2659116437","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659116437?lang=zh_cn&edition=full","pubTime":"2026-08-14 15:06","pubTimestamp":1786691179,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物08月14日在投资者关系平台上答复投资者关心的问题。目前，公司Reb M已具备规模化生产能力，可有效满足当前订单需求；该产品远期规划产能为3,000吨/年，后续将根据市场推广与需求释放节奏，分阶段逐步推进产能建设，感谢您的关注与支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400019682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659216179","title":"股市必读：三元生物(301206)股东户数1.54万户，较上期增加3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659216179","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659216179?lang=zh_cn&edition=full","pubTime":"2026-08-14 02:35","pubTimestamp":1786646113,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，三元生物报收于23.98元，上涨0.67%，换手率1.21%，成交量1.58万手，成交额3776.22万元。股本股东变化：截至2026年8月10日，三元生物股东户数为1.54万户，较7月31日增长3.04%。股本股东变化股东户数变动截至2026年8月10日公司股东户数为1.54万户，较7月31日增加454.0户，增幅为3.04%；户均持股数量由1.35万股减少至1.31万股，户均持股市值为31.64万元。董秘： 投资者您好，截至8月10日公司在册股东共15400户，谢谢关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400001586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659822131","title":"三元生物：截至8月10日公司在册股东共15400户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659822131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659822131?lang=zh_cn&edition=full","pubTime":"2026-08-13 15:06","pubTimestamp":1786604786,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问8月10日的股东人数是多少？三元生物回复：投资者您好，截至8月10日公司在册股东共15400户，谢谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300019557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658892840","title":"三元生物：阿洛酮糖业务整体保持稳健推进态势","url":"https://stock-news.laohu8.com/highlight/detail?id=2658892840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658892840?lang=zh_cn&edition=full","pubTime":"2026-08-12 11:37","pubTimestamp":1786505821,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物08月12日在投资者关系平台上答复投资者关心的问题。目前公司阿洛酮糖业务整体保持稳健推进态势，公司正采取“以销定产”的方式，有序释放新增产能。受益于全球对健康功能糖类产品需求的不断提升，海外客户对公司阿洛酮糖产品的认可度持续增强，相关订单与业务对接工作正在按计划有序展开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200016258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657952348","title":"三元生物（301206）披露对外投资进展暨完成工商变更登记公告，8月5日股价下跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657952348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657952348?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:34","pubTimestamp":1785940458,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，三元生物报收于23.65元，较前一交易日下跌0.17%，最新总市值为47.85亿元。三元生物于2026年8月5日发布《关于对外投资进展暨完成工商变更登记的公告》。公告显示，2026年7月6日，山东三元生物科技股份有限公司与深圳有维光电科技有限公司签署增资协议，使用自有资金向有维光电增资人民币3,000万元，其中140万元计入注册资本，2,860万元计入资本公积。交易完成后，三元生物持有有维光电10.7143%股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657565474","title":"股市必读：三元生物(301206)股东户数1.49万户，较上期增加0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657565474?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:59","pubTimestamp":1785869948,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，三元生物报收于23.69元，下跌0.08%，换手率0.78%，成交量1.02万手，成交额2409.77万元。股本股东变化股东户数变动截至2026年7月31日公司股东户数为1.49万户，较7月20日增加144.0户，增幅为0.97%。户均持股数量由上期的1.37万股减少至1.35万股，户均持股市值为31.74万元。董秘： 投资者您好，截至7月31日公司在册股东共14946户，谢谢关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788956872936,"stockEarnings":[{"period":"1week","weight":0.1203},{"period":"1month","weight":0.1519},{"period":"3month","weight":0.1698},{"period":"6month","weight":-0.0007},{"period":"1year","weight":-0.0788},{"period":"ytd","weight":0.0484}],"compareEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":0.0001},{"period":"3month","weight":-0.0132},{"period":"6month","weight":-0.0457},{"period":"1year","weight":0.0297},{"period":"ytd","weight":-0.0071}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东三元生物科技股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"14915人(较上一季度减少3.22%)","perCapita":"8735股","listingDate":"2022-02-10","address":"山东省滨州市滨城区滨北张富路89号","registeredCapital":"20232万元","survey":" 山东三元生物科技股份有限公司的主营业务是糖醇类、功能糖类及糖苷类健康甜味配料的研发、生产与销售。公司的主要产品是糖醇类、功能糖类及糖苷类健康甜味配料。公司已拥有40项国家发明专利和3项实用新型专利。","listedPrice":109.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三元生物,301206,三元生物股票,三元生物股票老虎,三元生物股票老虎国际,三元生物行情,三元生物股票行情,三元生物股价,三元生物股市,三元生物股票价格,三元生物股票交易,三元生物股票购买,三元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}